Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia

Autor: Bhusal S, Diomampo S, Magrey MN

Publikováno v: Drug, Healthcare and Patient Safety, Vol 2016, Iss Issue 1, Pp 13-23 (2016)

Santosh Bhusal,1 Sherilyn Diomampo,1 Marina N Magrey2 1Division of Rheumatology, Metrohealth Medical Center, 2Case Western Reserve University School of Medicine at Metrohealth Medical Center, Cleveland OH, USA Abstract: Fibromyalgia is a chronic debi

Externí odkaz: https://doaj.org/article/077ee8fa9b9f4a238a44deef58e6e594

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Thresholds for unacceptable work state in radiographic axial Spondyloarthritis of four presenteeism and two clinical outcome measurement instruments.

Autor: Capelusnik D; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands. Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Ramiro S; Department of Rheumatology, Leiden, University Medical Center, Leiden, the Netherlands. Department of Rheumatology, Zuyderland Medical Center, Heerlen, the Netherlands., Nikiphorou E; Centre for Rheumatic Diseases, King's College London, London, UK. Department of Rheumatology, King's College Hospital, London, UK., Maksymowych WP; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Magrey MN; Department of Rheumatology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Marzo-Ortega H; NIHR Leeds Biomedical Research Centre, LTHT and LIRMM, University of Leeds, Leeds, UK., Boonen A; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands. Department of Rheumatology, Maastricht University medical center, Maastricht, the Netherlands.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Jan 25. Date of Electronic Publication: 2024 Jan 25.

Efficacy and safety of Janus kinase inhibitors in axial spondyloarthritis.

Autor: Daoud A; Department of Rheumatology, Case Western Reserve University School of Medicine, University Hospitals, Cleveland, OH, United States., Magrey MN; Department of Rheumatology, Case Western Reserve University School of Medicine, University Hospitals, Cleveland, OH, United States.

Publikováno v: Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2023 Jun 21, pp. 1-9. Date of Electronic Publication: 2023 Jun 21.

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial.

Autor: Walsh JA; University of Utah School of Medicine and Salt Lake City Veterans Affairs Medical Center, Salt Lake City, Utah., Magrey MN; MetroHealth Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio., Baraliakos X; Ruhr-University Bochum, Bochum, Germany, and Osaka City University Graduate School of Medicine, Osaka, Japan., Inui K; Osaka City University Graduate School of Medicine, Osaka, Japan., Weng MY; National Cheng Kung University Medical College and Hospital, Tainan, Taiwan., Lubrano E; University of Molise, Campobasso, Italy., van der Heijde D; Leiden University Medical Center, Leiden, The Netherlands., Boonen A; Maastricht University Medical Center and Caphri Research Institute, Maastricht University, Maastricht, The Netherlands., Gensler LS; University of California, San Francisco., Strand V; Stanford University School of Medicine, Palo Alto, California., Braun J; Ruhr-University Bochum, Bochum, Germany, and Osaka City University Graduate School of Medicine, Osaka, Japan., Hunter T; Eli Lilly and Company, Indianapolis, Indiana., Li X; Eli Lilly and Company, Indianapolis, Indiana., Zhu B; Eli Lilly and Company, Indianapolis, Indiana., León L; Eli Lilly and Company, Indianapolis, Indiana., Calderon DMS; Eli Lilly and Company, Indianapolis, Indiana., Kiltz U; Ruhr-University Bochum, Bochum, Germany, and Osaka City University Graduate School of Medicine, Osaka, Japan.

Publikováno v: Arthritis care & research [Arthritis Care Res (Hoboken)] 2022 Mar; Vol. 74 (3), pp. 451-460. Date of Electronic Publication: 2022 Jan 26.